This Article Full Text Full Text (PDF) All Versions of this Article: 200509-1516PPv1 174/7/736    most recent Alert me when this article is cited Alert me if a correction is posted Services Related articles in AJRCCM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Richeldi, L. Search for Related Content PubMed PubMed Citation Articles by Richeldi, L.

An Update on the Diagnosis of Tuberculosis Infection

Respiratory Disease Clinic, Department of Oncology, Hematology, and Respiratory Disease, University of Modena and Reggio Emilia, Modena, Italy

Correspondence and requests for reprints should be addressed to Luca Richeldi, M.D., Ph.D., Department of Oncology, Hematology, and Respiratory Disease, University of Modena and Reggio Emilia, Policlinico Hospital, Via del Pozzo, 71-41100 Modena, Italy. E-mail: richeldi.luca{at}unimore.it

ABSTRACT

Targeted testing and treatment of individuals with latent tuberculosis infection at increased risk of progression to active disease is a key element of tuberculosis control. This strategy is limited by the poor specificity of the tuberculin skin test in populations vaccinated with bacille Calmette-Guérin and its low sensitivity in immunosuppressed persons, who are at highest risk of progression. Two blood tests (T-SPOT.TB and QuantiFERON-TB Gold), based on detection of IFN- released by T cells in response to M. tuberculosis–specific antigens, may offer an improvement on the skin test. However, validation is challenging due to the lack of a diagnostic gold standard. This critical appraisal of published evidence summarizes the diagnostic accuracy of the new tests. The blood tests have operational advantages over the skin test because no return visit is required, results are available by the next day, and repeated testing does not cause boosting. Both tests are significantly more specific than the skin test in populations vaccinated with bacille Calmette-Guérin. The data suggest that T-SPOT.TB may be more sensitive than the skin test. Data in groups at high risk of progression to disease are scarce, and more research is needed in these populations, but it is clear that T-SPOT.TB performs better than the skin test in young children and HIV-infected people with active tuberculosis. Incorporation of these tests into programs for targeted testing of latent tuberculosis infection will reduce false-positive and false-negative results inherent in tuberculin testing, equipping clinicians with more accurate tools for tuberculosis control and elimination in the 21st century.

Key Words: blood test • diagnosis • interferon- • tuberculosis

Related articles in AJRCCM:

Weighing Gold or Counting Spots: Which Is More Sensitive to Diagnose Latent Tuberculosis Infection?

Peter F. Barnes
AJRCCM 2006 174: 731-732. [Full Text]  

This article has been cited by other articles:

				C. B. E. Chee, S. H. Gan, K. W. KhinMar, T. M. Barkham, C. K. Koh, S. Liang, and Y. T. Wang Comparison of Sensitivities of Two Commercial Gamma Interferon Release Assays for Pulmonary Tuberculosis J. Clin. Microbiol., June 1, 2008; 46(6): 1935 - 1940. [Abstract] [Full Text] [PDF]

				A. Strassburg, C. Jafari, M. Ernst, W. Lotz, and C. Lange Rapid diagnosis of pulmonary TB by BAL enzyme-linked immunospot assay in an immunocompromised host Eur. Respir. J., May 1, 2008; 31(5): 1132 - 1135. [Abstract] [Full Text] [PDF]

				Y. Kobashi, K. Mouri, S. Yagi, Y. Obase, N. Miyashita, N. Okimoto, T. Matsushima, T. Kageoka, and M. Oka Clinical Utility of the QuantiFERON TB-2G Test for Elderly Patients With Active Tuberculosis Chest, May 1, 2008; 133(5): 1196 - 1202. [Abstract] [Full Text] [PDF]

				P. Beffa, A. Zellweger, J-P. Janssens, P. Wrighton-Smith, and J-P. Zellweger Indeterminate test results of T-SPOTTM.TB performed under routine field conditions Eur. Respir. J., April 1, 2008; 31(4): 842 - 846. [Abstract] [Full Text] [PDF]

				D. P.S. Dosanjh, T. S.C. Hinks, J. A. Innes, J. J. Deeks, G. Pasvol, S. Hackforth, H. Varia, K. A. Millington, R. Gunatheesan, V. Guyot-Revol, et al. Improved Diagnostic Evaluation of Suspected Tuberculosis Ann Intern Med, March 4, 2008; 148(5): 325 - 336. [Abstract] [Full Text] [PDF]

				C. C. Leung, W. C. Yam, W. W. Yew, P. L. Ho, C. M. Tam, W. S. Law, M. Y. Wong, M. Leung, and D. Tsui Comparison of T-Spot.TB and tuberculin skin test among silicotic patients Eur. Respir. J., February 1, 2008; 31(2): 266 - 272. [Abstract] [Full Text] [PDF]

				C. Jafari, M. Ernst, A. Strassburg, U. Greinert, B. Kalsdorf, D. Kirsten, and C. Lange Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot Eur. Respir. J., February 1, 2008; 31(2): 261 - 265. [Abstract] [Full Text] [PDF]

				R. Palazzo, F. Spensieri, M. Massari, G. Fedele, L. Frasca, S. Carrara, D. Goletti, and C. M. Ausiello Use of Whole-Blood Samples in In-House Bulk and Single-Cell Antigen-Specific Gamma Interferon Assays for Surveillance of Mycobacterium tuberculosis Infections Clin. Vaccine Immunol., February 1, 2008; 15(2): 327 - 337. [Abstract] [Full Text] [PDF]

				M. Losi, A. Bossink, L. Codecasa, C. Jafari, M. Ernst, S. Thijsen, D. Cirillo, M. Ferrarese, U. Greinert, L. M. Fabbri, et al. Use of a T-cell interferon-{gamma} release assay for the diagnosis of tuberculous pleurisy Eur. Respir. J., December 1, 2007; 30(6): 1173 - 1179. [Abstract] [Full Text] [PDF]

				A. Pratt, K. Nicholl, and L. Kay Comment on: Use of the QuantiFERON-TB(R) Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-{alpha} agents: the Newcastle (UK) experience: reply Rheumatology, December 1, 2007; 46(12): 1864 - 1865. [Full Text] [PDF]

				M. G. Madariaga, Z. Jalali, and S. Swindells Clinical Utility of Interferon Gamma Assay in the Diagnosis of Tuberculosis J Am Board Fam Med, November 1, 2007; 20(6): 540 - 547. [Abstract] [Full Text] [PDF]

				Y. Kobashi, K. Mouri, Y. Obase, M. Fukuda, N. Miyashita, and M. Oka Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Eur. Respir. J., November 1, 2007; 30(5): 945 - 950. [Abstract] [Full Text] [PDF]

				U. R. Dahle, V. Eldholm, B. A. Winje, T. Mannsaker, and E. Heldal Impact of Immigration on the Molecular Epidemiology of Mycobacterium tuberculosis in a Low-Incidence Country Am. J. Respir. Crit. Care Med., November 1, 2007; 176(9): 930 - 935. [Abstract] [Full Text] [PDF]

				J-P. Janssens, P. Roux-Lombard, T. Perneger, M. Metzger, R. Vivien, and T. Rochat Quantitative scoring of an interferon-{gamma} assay for differentiating active from latent tuberculosis Eur. Respir. J., October 1, 2007; 30(4): 722 - 728. [Abstract] [Full Text] [PDF]

				Y. A. Kang, H. W. Lee, S. S. Hwang, S.-W. Um, S. K. Han, Y.-S. Shim, and J.-J. Yim Usefulness of Whole-Blood Interferon-{gamma} Assay and Interferon-{gamma} Enzyme-Linked Immunospot Assay in the Diagnosis of Active Pulmonary Tuberculosis Chest, September 1, 2007; 132(3): 959 - 965. [Abstract] [Full Text] [PDF]

				T. G. Connell, M. S. Shey, R. Seldon, M. X. Rangaka, G. van Cutsem, M. Simsova, Z. Marcekova, P. Sebo, N. Curtis, L. Diwakar, et al. Enhanced Ex Vivo Stimulation of Mycobacterium tuberculosis-Specific T Cells in Human Immunodeficiency Virus-Infected Persons via Antigen Delivery by the Bordetella pertussis Adenylate Cyclase Vector Clin. Vaccine Immunol., July 1, 2007; 14(7): 847 - 854. [Abstract] [Full Text] [PDF]

				A. Lalvani Diagnosing Tuberculosis Infection in the 21st Century: New Tools To Tackle an Old Enemy Chest, June 1, 2007; 131(6): 1898 - 1906. [Abstract] [Full Text] [PDF]

				J. K. Reid, H. Ward, D. Marciniuk, S. Hudson, P. Smith, and V. Hoeppner The Effect of Neonatal Bacille Calmette-Guerin Vaccination on Purified Protein Derivative Skin Test Results in Canadian Aboriginal Children Chest, June 1, 2007; 131(6): 1806 - 1810. [Abstract] [Full Text] [PDF]

				B. J Marais and M. Pai Recent advances in the diagnosis of childhood tuberculosis Arch. Dis. Child., May 1, 2007; 92(5): 446 - 452. [Abstract] [Full Text] [PDF]

				M. X. Rangaka, K. A. Wilkinson, R. Seldon, G. Van Cutsem, G. A. Meintjes, C. Morroni, P. Mouton, L. Diwakar, T. G. Connell, G. Maartens, et al. Effect of HIV-1 Infection on T-Cell-based and Skin Test Detection of Tuberculosis Infection Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 514 - 520. [Abstract] [Full Text] [PDF]

				L. Richeldi Should Individuals Who Are Tuberculin Skin Test Negative and Positive to RD1-IFN-{gamma} Assay Receive Preventive Therapy? Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 200 - 200. [Full Text] [PDF]

				E. Girardi, D. Goletti, and G. Ippolito Should Individuals Who Are Tuberculin Skin Test Negative and Positive to RD1-IFN-{gamma} Assay Receive Preventive Therapy? Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 198a - 199. [Full Text] [PDF]

				A. J. Radford, J. S. Rothel, S. L. Jones, and G. Sberna Tuberculosis diagnostic tests: sensitivity, specificity, and comparing apples with apples. Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 953 - 953. [Full Text] [PDF]

				L. Richeldi Tuberculosis diagnostic tests: sensitivity, specificity, and comparing apples with apples. Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 953a - 9954. [Full Text] [PDF]

				P. F. Barnes Weighing gold or counting spots: which is more sensitive to diagnose latent tuberculosis infection? Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 731 - 732. [Full Text] [PDF]